ArticleBMC cancer2019
A TMEFF2-regulated cell cycle derived gene signature is prognostic of recurrence risk in prostate cancer.
Constantin Georgescu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it